All treatments
Treatment
Ovitrelle 250 micrograms/0.5 mL solution for injection in pre-filled syringe clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedPhase III and phase IV (Integrated)
A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme
This study is looking at two different hormone medicines, Rekovelle and Menopur, used in fertility treatments like IVF. Researchers want to see which one helps women produce more good-quality eggs. It aims to improve chances of pregnancy for women needing fertility help.
For: Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleItaly · Spain - Ongoing, recruitingTherapeutic use (Phase IV)
The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial.
This study looks at different ways to give fertility medicines to women who might find it harder to get pregnant. We want to see if changing the amount of medicine helps create better-quality embryos, which could improve chances of pregnancy.
For: infertilitySpain